Skip to main content
RLAY filings

Corporate insider profile

Thomas Catinazzo Filing Activity

Latest reported as Chief Financial Officer of Relay Therapeutics, Inc. (RLAY).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,127,100.13
Latest transaction
Aug 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 14, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$19.74$349,734
Jul 28, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale1,459$18.61$27,152
Jul 6, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$18.69$331,131